Marc Mansour

Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients

Neil L. Berinstein, Mohan Karkada, Amit M. Oza et al. · OncoImmunology · 2015 · 98 citations · Full text

First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients

Neil L. Berinstein, Mohan Karkada, Michael A. Morse et al. · Journal of Translational Medicine · 2012 · 84 citations · Full text

Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion

Pirouz Daftarian, Marc Mansour, Anita C. Benoit et al. · Vaccine · 2006 · 83 citations

Vaccination, Mucosal Vaccination, Vaccine Research +11

Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1.

ML Rand, Jeffrey S. Warren, Marc Mansour et al. · PubMed · 1996 · 81 citations

Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines

Genevieve Weir, Robert Liwski, Marc Mansour · Cancers · 2011 · 77 citations · Full text

Vaccination, Tumor Immunology, Cancer Immunosurveillance +15